282 Use of the humanized anti-EGFR antibody h-R3 and radiotherapy for the treatment of patients with high-grade astrocytic tumors

T.Crombet; J.Figueredo; M.Catalá; S.González; J.Selva; C.Toledo; O.Torres; R.Pérez; A.Lage

首页> 外文期刊>European Journal of Cancer Supplements >282 Use of the humanized anti-EGFR antibody h-R3 and radiotherapy for the treatment of patients with high-grade astrocytic tumors

【24h】

282 Use of the humanized anti-EGFR antibody h-R3 and radiotherapy for the treatment of patients with high-grade astrocytic tumors

机译：282人源化抗EGFR抗体h-R3和放射疗法在治疗高度星形细胞肿瘤中的应用

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2004年第8期|共2页
作者
T.Crombet; J.Figueredo; M.Catalá; S.González; J.Selva; C.Toledo; O.Torres; R.Pérez; A.Lage;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 199 POSTER Efficacy evaluation of the humanized anti-EGFR MAb h-R3 (nimotuzumab) in combination with radiotherapy in the treatment of patients with unresectable squamous cell carcinomas of the head and neck [J] . T.Crombet, M.Osorio, T.Cruz, European Journal of Cancer Supplements . 2006,第12期

机译：199 POSTER人源化抗EGFR MAb h-R3（尼莫妥珠单抗）联合放疗治疗无法切除的头颈部鳞状细胞癌的疗效
2. Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: report from a phase I/II trial. [J] . Ramos TC, Figueredo J, Catala M, Cancer biology & therapy . 2006,第4期

机译：使用人源化抗表皮生长因子受体（EGFR）抗体h-R3治疗高级神经胶质瘤患者：I / II期试验报告。
3. Use of the Humanized Anti-Epidermal Growth Factor Receptor Monoclonal Antibody h-R3 in Combination With Radiotherapy in the Treatment of Locally Advanced Head and Neck Cancer Patients. [J] . Crombet T, Osorio M, Cruz T, Journal of Clinical Oncology . 2004,第9期

机译：人源化抗表皮生长因子受体单克隆抗体h-R3与放疗联合用于治疗局部晚期头颈癌患者。
4. 188Re-Labelled Anti-EGFr Humanised Monoclonal Antibody h-R3 forradioimmunotherapy [C] . Alejandro Perera, Gerardo Lopez, Angel Casaco, Trends in Radiopharmaceuticals(ISTR-2005) . 2007

机译：188Re-Labelled抗EGFr人源化单克隆抗体h-R3用于放射免疫治疗
5. In Vitro Characterization of a Fully Humanized Anti-Thymoglobulin Antibodies, “SAB-142” for the Treatment of Type 1 Diabetes and Transplantation Rejection [D] . Patlola, Rama Devi. 2021

机译：体外表征全人源化的抗胸膜蛋白抗体，“SAB-142”用于治疗1型糖尿病和移植排斥反应
6. Comment on ‘Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study’ [O] . Matthew Dankner, April A. N. Rose 2018

机译：评论 BRAF non-V600E突变对转移性结直肠癌预治疗的抗EGFR单克隆抗体治疗的临床意义：通过综合癌症基因组学（BREAC）研究抗EGFR单克隆抗体的生物标志物研究
7. Comment on ‘Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study’ [O] . Matthew Dankner, April A. N. Rose 2018

机译：评论对预处理转移性结直肠癌患者抗EGFR单克隆抗体治疗抗EGFR单克隆抗体治疗的临床意义：综合癌症基因组学（BREAC）研究对抗EGFR单克隆抗体的生物标志物研究'

282 Use of the humanized anti-EGFR antibody h-R3 and radiotherapy for the treatment of patients with high-grade astrocytic tumors

著录项

引文网络

相似文献

相关主题

期刊订阅